Understanding Scleroderma and the Johns Hopkins Scleroderma Center
Scleroderma is an often misunderstood autoimmune condition that leads to hardening and tightening of the skin and connective tissues. The Johns Hopkins Scleroderma Center is a leading research and treatment center for this complex disease.
What is Scleroderma?
Scleroderma means hard skin which comes from the hallmark symptom of thick, tight skin that can occur with this progressive condition. The hardening is caused by an overproduction of collagen.
In scleroderma, the bodys immune system malfunctions and starts generating inflammation and antibody activity that damages tissues. This interferes with blood vessel function and promotes an excessive collagen accumulation.
While scleroderma primarily affects the skin, it often involves other areas like blood vessels, joints, muscles, and internal organs. This can impair normal functioning of body systems.
Types of Scleroderma
There are two main types of scleroderma:
- Localized scleroderma - Just affects the skin and tissue under it such as fat and muscle of specific areas. This type of scleroderma typically develops in childhood through early adulthood.
- Systemic sclerosis - Impacts the whole body by damaging internal organs in addition to skin hardening. Onset is usually between ages 30-50.
Both types of scleroderma have the potential to be seriously debilitating in their impacts on daily life.
Who Gets Scleroderma?
About 300,000 Americans have scleroderma with women developing it 4-9 times more frequently than men. While it can occur at any age, localized scleroderma tends to strike earlier while systemic sclerosis emerges later.
People between ages 30-50 are most affected by systemic scleroderma which is the more severe form. Native Americans and African Americans also seem to have higher risk.
Symptoms
Signs and symptoms depend greatly on the type, severity, and areas affected. Some common problems are:
- Thick, tight skin, especially of the hands
- Calcium deposits under the skin
- Pain, swelling, numbness, and tissue damage in fingers or toes
- Tight facial skin with small mouth opening
- Digestive issues like reflux, bloating, constipation
- Kidney disease
- Shortness of breath or cough from lung involvement
- Heartburn or difficulty swallowing when esophagus affected
- Joint pain with loss of range of motion
The Johns Hopkins Scleroderma Center
The Johns Hopkins Scleroderma Center is a pioneer in innovative scleroderma research and patient care. It takes a comprehensive multispecialty approach to managing this disease.
Team of Experts
The Center brings together a diverse team of specialists under one roof to evaluate and treat every aspect of sclerodermas impacts.
Rheumatologists, pulmonologists, cardiologists, gastroenterologists, nephrologists, dermatologists, physical therapists, and nurses collaborate to provide whole body care customized to each patients manifestations.
Cutting-Edge Research
In addition to individualized patient care, the Johns Hopkins Scleroderma Center prioritizes pushing forward scientific understanding of the mechanisms driving this condition.
Active analysis goes on examining biomarkers, genetic risk factors, and other intricacies holding promise for future diagnostic and treatment advancements.
Patient Resources
Having a major health condition with many medical, emotional, and lifestyle implications can feel overwhelming. Thats why the Johns Hopkins Scleroderma Center also emphasizes patient and caregiver education and support.
From tips on managing specific symptoms to mindfulness techniques to peer support groups, resources empower patients to be active participants in their healthcare journeys.
Diagnosing Scleroderma
Getting an accurate scleroderma analysis involves multiple types of assessments to determine the subtype present and degree of progression.
Medical History
Doctors first extensively review an individuals health background looking for suggestive symptoms and timing of their emergence. A detailed family history is also taken to assess genetic risk.
Physical Exam
Methodical physical examination helps categorize skin characteristics like tightness, thickness, hair loss, small blood vessel visibility, finger ulcers, and calcium deposits.
Testing range of motion, listening to heart and lungs, palpating the abdomen, and evaluating other areas paints a clinical picture.
Diagnostic Tests
Various lab tests and imaging scans further pinpoint organ involvement and abnormalities to distinguish localized cutaneous vs systemic disease.
- Blood tests - Check inflammatory markers, antibodies, and proteins indicative of scleroderma.
- Skin biopsy - Microscopic inspection of skin samples defines skin layer impacts.
- Pulmonary function tests - Breathing capacity assessments uncover lung damage.
- EKG and echocardiogram - Heart electrical activity and structure evaluated for fibrosis.
- X-rays and CT scans - Imaging tests identify organ disease patterns consistent with scleroderma.
Johns Hopkins Scleroderma Treatment Approaches
Early, aggressive scleroderma treatment is crucial to prevent rapid progression and irreversible complications. Johns Hopkins utilizes leading therapies.
Medications
Various systemic medications help constrain overactive immune functioning and inflammation in scleroderma such as:
- Corticosteroids
- Immunosuppressants
- Biologics
Blood pressure and heart medications treat related vascular complications. The Center tailors combinations to each patients manifestations.
Lifestyle Changes
Self-care enhancements also improve scleroderma coping ability such as:
- Quitting smoking
- Avoiding cold exposure
- Managing emotional stress
- Gentle range-of-motion exercises
- Healthy nutrition
Johns Hopkins occupational and physical therapists guide lifestyle adaptations for better function.
Advanced Therapies
Pioneering clinical trials provide access to developing treatments like:
- Stem cell transplants to regenerate damaged tissue
- Laser light technology to improve skin pliability
- Microbiome manipulation to influence gut immunity
The Johns Hopkins Scleroderma Center constantly strives to expand leading-edge options for restoring patient vitality.
The Future of Scleroderma Care
While there is currently no cure for scleroderma, the outlook for enhanced management continues advancing through discoveries by Johns Hopkins Medicine and other top centers.
Early diagnosis, prompt treatment, symptomatic vigilance, and staying on top of next-gen interventions helps preserve best possible quality of life.
Collaborating with a knowledgeable multidisciplinary team like that of the Johns Hopkins Scleroderma Center gives patients the power to take charge of managing this disease.
FAQs
What is the Johns Hopkins Scleroderma Center?
The Johns Hopkins Scleroderma Center is a leading research and treatment center bringing together specialists in rheumatology, pulmonology, cardiology, gastroenterology, and more to provide comprehensive scleroderma care.
What are the main symptoms of scleroderma?
Major symptoms involve thick, tight skin, especially of the hands and face. But systemic scleroderma also damages blood vessels and internal organs leading to issues like kidney disease, breathing problems, gi dysfunction, and joint pain.
How do doctors diagnose scleroderma?
Diagnosis involves a medical history review, physical exam of the skin and organs, blood tests checking for antibodies and proteins, skin biopsy, imaging tests, and special function tests to determine impacts on lungs, heart, kidneys, and digestion.
What new scleroderma treatments are being studied?
The Johns Hopkins Scleroderma Center provides access to pioneering options in clinical trials like stem cell transplants to regenerate tissue, laser light skin treatments, and manipulation of gut microbiome function.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a healthcare professional before starting any new treatment regimen.
Add Comment